JP2003519621A5 - - Google Patents

Download PDF

Info

Publication number
JP2003519621A5
JP2003519621A5 JP2001534362A JP2001534362A JP2003519621A5 JP 2003519621 A5 JP2003519621 A5 JP 2003519621A5 JP 2001534362 A JP2001534362 A JP 2001534362A JP 2001534362 A JP2001534362 A JP 2001534362A JP 2003519621 A5 JP2003519621 A5 JP 2003519621A5
Authority
JP
Japan
Prior art keywords
metformin
glyburide
dose
treatment
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001534362A
Other languages
English (en)
Japanese (ja)
Other versions
JP5183844B2 (ja
JP2003519621A (ja
Filing date
Publication date
Priority claimed from US09/432,465 external-priority patent/US6586438B2/en
Application filed filed Critical
Priority claimed from PCT/US2000/028311 external-priority patent/WO2001032157A2/en
Publication of JP2003519621A publication Critical patent/JP2003519621A/ja
Publication of JP2003519621A5 publication Critical patent/JP2003519621A5/ja
Application granted granted Critical
Publication of JP5183844B2 publication Critical patent/JP5183844B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001534362A 1999-11-03 2000-10-13 糖尿病の治療方法 Expired - Fee Related JP5183844B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/432,465 US6586438B2 (en) 1999-11-03 1999-11-03 Antidiabetic formulation and method
US09/432,465 1999-11-03
US09/460,920 1999-12-14
US09/460,920 US7598262B2 (en) 1999-11-03 1999-12-14 Method for treating diabetes
PCT/US2000/028311 WO2001032157A2 (en) 1999-11-03 2000-10-13 Pharmaceutical composition comprising a combination of metformin and glibenclamide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012211400A Division JP2013028631A (ja) 1999-11-03 2012-09-25 糖尿病の治療方法

Publications (3)

Publication Number Publication Date
JP2003519621A JP2003519621A (ja) 2003-06-24
JP2003519621A5 true JP2003519621A5 (cg-RX-API-DMAC7.html) 2007-11-29
JP5183844B2 JP5183844B2 (ja) 2013-04-17

Family

ID=27029501

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001534362A Expired - Fee Related JP5183844B2 (ja) 1999-11-03 2000-10-13 糖尿病の治療方法

Country Status (23)

Country Link
EP (1) EP1229918B1 (cg-RX-API-DMAC7.html)
JP (1) JP5183844B2 (cg-RX-API-DMAC7.html)
KR (1) KR20070089259A (cg-RX-API-DMAC7.html)
CN (1) CN1450902A (cg-RX-API-DMAC7.html)
AR (1) AR026356A1 (cg-RX-API-DMAC7.html)
AT (1) ATE390140T1 (cg-RX-API-DMAC7.html)
AU (1) AU780106B2 (cg-RX-API-DMAC7.html)
BR (1) BR0015294A (cg-RX-API-DMAC7.html)
CA (1) CA2389928C (cg-RX-API-DMAC7.html)
EE (1) EE05260B1 (cg-RX-API-DMAC7.html)
HU (1) HU229352B1 (cg-RX-API-DMAC7.html)
IL (1) IL149139A0 (cg-RX-API-DMAC7.html)
LT (1) LT5058B (cg-RX-API-DMAC7.html)
LV (1) LV12910B (cg-RX-API-DMAC7.html)
MX (1) MXPA02004282A (cg-RX-API-DMAC7.html)
NO (1) NO330026B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ518278A (cg-RX-API-DMAC7.html)
PL (1) PL199278B1 (cg-RX-API-DMAC7.html)
RU (1) RU2275915C2 (cg-RX-API-DMAC7.html)
SK (1) SK287810B6 (cg-RX-API-DMAC7.html)
TW (1) TWI280125B (cg-RX-API-DMAC7.html)
UY (1) UY26424A1 (cg-RX-API-DMAC7.html)
WO (1) WO2001032157A2 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
FR2816840B1 (fr) 2000-11-17 2004-04-09 Flamel Tech Sa Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation
FR2825023B1 (fr) * 2001-05-23 2005-04-15 Flamel Tech Sa Forme pharmaceutique orale antidiabetique "une prise par jour"comprenant une biguanide et au moins un autre principe actif
WO2003011273A1 (en) * 2001-07-31 2003-02-13 The Governement Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Metformin in the treatment of hyperglycemic conditions
JP4732696B2 (ja) 2002-04-09 2011-07-27 フラメル・テクノロジー 活性成分の改変された放出のための、マイクロカプセルの水性懸濁液形態での経口医薬品製剤
PL376577A1 (pl) 2002-06-17 2006-01-09 Themis Laboratories Private Limited Wielowarstwowe tabletki zawierające tiazolidinedion i biguanidy oraz metody ich wytwarzania
JP2007509865A (ja) * 2003-10-30 2007-04-19 ティオガ ファーマシュウティカルズ,インコーポレイテッド 神経障害の治療における選択的オピエート受容体調節物質の使用
TWI350751B (en) * 2003-12-19 2011-10-21 Omega Bio Pharma Ip3 Ltd Pharmaceutical compositions for treating diabetes
AU2005240122B2 (en) * 2004-05-03 2011-02-17 Omega Bio-Pharma (I.P.3) Limited Cysteamines for treating complications of hypercholesterolemia and diabetes
AR067557A1 (es) 2007-07-19 2009-10-14 Takeda Pharmaceutical Preparacion solida y metodo de preparacion
MX2010002695A (es) 2007-09-10 2010-04-01 Janssen Pharmaceutica Nv Proceso para la preparacion de compuestos utiles como inhibidores de transportador de glucosa dependiente de sodio (sglt).
RU2372911C1 (ru) * 2008-03-12 2009-11-20 Николай Евгеньевич Староверов Полиморфная аналоговая терапия
US9056850B2 (en) 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
JP5832439B2 (ja) 2009-11-13 2015-12-16 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Glp−1アゴニスト、インスリン及びメチオニンを含む薬学的組成物
SG10201500871TA (en) 2009-11-13 2015-04-29 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
NZ703128A (en) 2010-05-11 2016-04-29 Janssen Pharmaceutica Nv Pharmaceutical formulations comprising 1 - (beta-d-glucopyranosyl) - 2 -thienylmethylbenzene derivatives as inhibitors of sglt
CN103179978A (zh) 2010-08-30 2013-06-26 赛诺菲-安万特德国有限公司 Ave0010用于制造供治疗2型糖尿病用的药物的用途
JP6381914B2 (ja) * 2011-02-02 2018-08-29 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 2型糖尿病患者における低血糖の予防
US20120277147A1 (en) * 2011-03-29 2012-11-01 Sanofi-Aventis Deutschland Gmbh Prevention of hypoglycaemia in diabetes mellitus type 2 patients
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療
US20170071970A1 (en) 2015-09-15 2017-03-16 Janssen Pharmaceutica Nv Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
CN110804017A (zh) * 2019-10-31 2020-02-18 天津大学 磺酰脲化合物与二甲双胍成盐、制备方法和应用
CN113143940A (zh) * 2020-12-30 2021-07-23 成都恒瑞制药有限公司 一种抗糖尿病药物组合物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3174901A (en) 1963-01-31 1965-03-23 Jan Marcel Didier Aron Samuel Process for the oral treatment of diabetes
DE3833439A1 (de) * 1988-10-01 1991-09-12 Hoechst Ag Verfahren zur mikronisierung von glibenclamid
DK36392D0 (da) 1992-03-19 1992-03-19 Novo Nordisk As Anvendelse af kemisk forbindelse
TW438587B (en) 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
TR199903057T2 (xx) 1997-06-18 2000-04-21 Smithkline Beecham Plc Diabetin tiazolidinedion ve metformin ile tedavisi.
CA2312990C (en) * 1997-12-08 2008-04-29 Bristol-Myers Squibb Company Novel salts of metformin and method
DE69818444T2 (de) * 1998-07-15 2004-05-06 Merck Santé Tabletten enthaltend eine Kombination von Glibenclamid und Metformin
EP2620443A1 (en) 2012-01-25 2013-07-31 Galecto Biotech AB Novel galactoside inhibitors of galectins

Similar Documents

Publication Publication Date Title
JP5183844B2 (ja) 糖尿病の治療方法
KR100769786B1 (ko) 메트포르민 및 글리벤클아미드의 복합을 포함하는 제약조성물
US7507768B2 (en) Antidiabetic formulation and method
AU8022900B2 (cg-RX-API-DMAC7.html)
AU2002357095B2 (en) Antidiabetic formulation and method